Ospedale Regionale Bellinzona e Valli

Bellinzona CH-6500

2 studies enrolling now · 3 studies all time

What they study most

Chronic Lymphocytic Leukemia, Fallopian Tube Neoplasms, Neoplasm Metastasis, Non-small Cell Lung Cancer (NSCLC), Ovarian Neoplasms, Peritoneal Neoplasms, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) — Recruiting now
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling